脂毒性在肌少症发生发展中作用的研究进展

doi:10.16352/j.issn.1001-6325.2023.12.1886

基础医学与临床 ›› 2023, Vol. 43 ›› Issue (12): 1886-1890.doi: 10.16352/j.issn.1001-6325.2023.12.1886

脂毒性在肌少症发生发展中作用的研究进展

蒋琪¹, 杨柳¹, 和娇娇¹, 李维辛^2*

1.兰州大学第一临床医学院,甘肃兰州 730000;
2.兰州大学第一医院老年病科二病区,甘肃兰州 730000

收稿日期:2023-06-27 修回日期:2023-10-24 出版日期:2023-12-05 发布日期:2023-11-29
通讯作者: ^* 1051742798@qq.com
基金资助:
甘肃省自然科学基金(22JR5RA925)

Progress of research on role of lipotoxicity in pathogenesis of sarcopenia

JIANG Qi¹, YANG Liu¹, HE Jiaojiao¹, LI Weixin^2*

1. The First Clinical Medical College of Lanzhou University, Lanzhou 730000;
2. the Second Department of Gerontology,the First Hospital of Lanzhou University,Lanzhou 730000,China

Received:2023-06-27 Revised:2023-10-24 Online:2023-12-05 Published:2023-11-29
Contact: ^* 1051742798@qq.com

摘要/Abstract

摘要： 肌肉减少症(肌少症)是老年人不可忽视的健康问题。肥胖老年人肌少症的发生可能与游离脂肪酸、甘油二酯、神经酰胺等脂毒性物质在细胞内蓄积对骨骼肌细胞造成的脂毒性息息相关。脂毒性物质通过诱导骨骼肌细胞炎性反应、氧化应激、内质网应激、胰岛素抵抗,导致骨骼肌细胞蛋白质代谢紊乱和再生障碍,最终导致肌少症的发生。目前,骨骼肌脂毒性导致肌少症发生发展的机制并不完全明确,进一步的深入研究可能给肌少症的预防和诊治带来新的方向。

关键词: 游离脂肪酸, 脂毒性, 肌少症, 发病机制

Abstract: Sarcopenia is a serious health concern that must be payed attention by aged people. The occurrence of sarcopenia in obese older individuals may be intricately linked to lipotoxic substances such as free fatty acids (FFA), diacylglycerols (DAG), and ceramides, which are toxic to skeletal muscle cells. Lipotoxic substances induce inflammatory responses, oxidative stress, endoplasmic reticulum stress, and insulin resistance in skeletal muscle cells, disrupting protein metabolism and impairing regeneration and then lead to the onset of sarcopenia. Up to the present, the precise mechanisms by which lipotoxicity in skeletal muscle results in the development of sarcopenia remain incompletely understood. Further research may highlight the orientation for the prevention and treatment of sarcopenia.

Key words: free fatty acids, lipotoxicity, sarcopenia, pathogenesis

中图分类号:

R589.2

蒋琪, 杨柳, 和娇娇, 李维辛. 脂毒性在肌少症发生发展中作用的研究进展[J]. 基础医学与临床, 2023, 43(12): 1886-1890.

JIANG Qi, YANG Liu, HE Jiaojiao, LI Weixin. Progress of research on role of lipotoxicity in pathogenesis of sarcopenia[J]. Basic & Clinical Medicine, 2023, 43(12): 1886-1890.

参考文献 21

[1]	Perissiou M, Borkoles E, Kobayashi K, et al. The effect of an 8 week prescribed exercise and low-carbohydrate diet on cardiorespiratory fitness, body composition and cardiometabolic risk factors in obese individuals: a randomised controlled Trial[J]. Nutrients, 2020, 12:482.doi: 10.3390/nu12020482.
[2]	Corsetto PA, Montorfano G, Klersy C, et al. Fatty acid profile and antioxidant status fingerprint in sarcopenic elderly patients: role of diet and exercise[J]. Nutrients, 2019, 11:2569.doi: 10.3390/nu11112569.
[3]	Zheng P, Wu H, Gu Y, et al. Atorvastatin ameliorates lipid overload-induced mitochondrial dysfunction and myocardial hypertrophy by decreasing fatty acid oxidation through inactivation of the p-STAT3/CPT1 pathway[J]. Biomed Pharmacother, 2023, 157: 114024.doi: 10.1016/j.biopha.2022.114024.
[4]	Blackburn ML, Ono-Moore KD, Sobhi HF, et al. Carnitine palmitoyltransferase 2 knockout potentiates palmitate-induced insulin resistance in C(2)C(12) myo-tubes[J]. Am J Physiol Endocrinol Metab, 2020, 319: E265-E275.
[5]	Sergi D, Morris AC, Kahn DE, et al. Palmitic acid triggers inflammatory responses in N42 cultured hypothalamic cells partially via ceramide synthesis but not via TLR4[J]. Nutr Neurosci, 2020, 23: 321-334.
[6]	Kim M, Song K, Kim YS. Alantolactone improves palmitate-induced glucose intolerance and inflammation in both lean and obese states in vitro: adipocyte and adipocyte-macrophage co-culture system[J]. Int Immunopharmacol, 2017, 49: 187-194.
[7]	Grujic-Milanovic JD, Miloradovic ZZ, Mihailovic-Stanojevic ND, et al. Excesive consumption of unsaturated fatty acids leads to oxidative and inflammatory instability in Wistar rats[J]. Biomed Pharmacother, 2021, 139: 111691.doi: 10.1016/j.biopha.2021.111691.
[8]	党彩虹,李维辛. 脂肪因子在老年人肌少症发病中作用的研究进展[J]. 基础医学与临床, 2023, 43: 695-699.
[9]	Dludla PV, Nkambule BB, Jack B, et al. Inflammation and oxidative stress in an obese state and the protective effects of gallic acid[J]. Nutrients, 2018, 11:23.doi: 10.3390/nu11010023.
[10]	Banerjee A, Das D, Paul R, et al. Altered composition of high-lipid diet may generate reactive oxygen species by disturbing the balance of antioxidant and free radicals[J]. J Basic Clin Physiol Pharmacol, 2020, 31.doi: 10.1515/jbcpp-2019-0141.
[11]	Lee SR, Jo SL, Heo JH, et al. The aqueous fraction of Castanea crenata inner shell extract reduces obesity and intramuscular lipid accumulation via induction of mitochondrial respiration and fatty acid oxidation in muscle[J]. Phytomedicine, 2022, 98: 153974.doi: 10.1016/j.phymed.2022.153974.
[12]	Rivera ME, Vaughan RA. Comparing the effects of palmitate, insulin, and palmitate-insulin co-treatment on myotube metabolism and insulin resistance[J]. Lipids, 2021, 56: 563-578.
[13]	Yue XY, Sun XF, Che K, et al. Lpl-C310R mutation is associated with impaired glucose tolerance and endoplasmic reticulum stress in skeletal muscle[J]. Biochem Biophys Res Commun, 2020, 529: 480-486.
[14]	McNally BD, Ashley DF, Hanschke L, et al. Long-chain ceramides are cell non-autonomous signals linking lipotoxicity to endoplasmic reticulum stress in skeletal muscle[J]. Nat Commun, 2022, 13: 1748.doi: 10.1038/s41467-022-29363-9.
[15]	Kashyap B, Barge SR, Bharadwaj S, et al. Evaluation of therapeutic effect of Premna herbacea in diabetic rat and isoverbascoside against insulin resistance in L6 muscle cells through bioenergetics and stimulation of JNK and AKT/mTOR signaling cascade[J]. Phytomedicine, 2021, 93: 153761.doi: 10.1016/j.phymed.2021.153761.doi: 10.3390/cells12060920.
[16]	Vilchinskaya NA, Rozhkov SV, Turtikova OV, et al. AMPK phosphorylation impacts apoptosis in differentiat-ing myoblasts isolated from atrophied rat soleus muscle[J]. Cells, 2023, 12:920.doi: 10.3390/cells12060920.
[17]	Verpoorten S, Sfyri P, Scully D, et al. Loss of CD36 protects against diet-induced obesity but results in impaired muscle stem cell function, delayed muscle regeneration and hepatic steatosis[J]. Acta Physiol (Oxf), 2020, 228: e13395.doi: 10.1111/apha.13395.
[18]	Pereyra AS, Rajan A, Ferreira CR, et al. Loss of muscle carnitine palmitoyltransferase 2 prevents diet-induced obesity and insulin resistance despite long-chain acylcarnitine accumulation [J]. Cell Rep, 2020, 33: 108374.doi: 10.1016/j.celrep.2020.108374.
[19]	Takehara M, Kobayashi K, Nagahama M. Clostridium perfringens alpha-toxin inhibits myogenic differentiation of C2C12 myoblasts[J]. Anaerobe, 2020, 65: 102265.doi: 10.1016/j.anaerobe.2020.102265.
[20]	Sencan C, Dost FS, Ates Bulut E, et al. DPP4 inhibitors as a potential therapeutic option for sarcopenia: A 6-month follow-up study in diabetic older patients[J]. Exp Gerontol, 2022, 164: 111832.doi: 10.1016/j.exger.2022.111832.
[21]	Ishii S, Nagai Y, Sada Y, et al. Liraglutide reduces visceral and intrahepatic fat without significant loss of muscle mass in obese patients with type 2 diabetes: A prospective case series[J]. J Clin Med Res, 2019, 11: 219-224.

脂毒性在肌少症发生发展中作用的研究进展

Progress of research on role of lipotoxicity in pathogenesis of sarcopenia

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 21

相关文章 15

编辑推荐

Metrics

本文评价

[1]	苏凌峰, 王虎霞, 王延峰, 宋张骏. 慢性压力对乳腺癌发展的影响[J]. 基础医学与临床, 2024, 44(9): 1303-1307.
[2]	彭晴怡, 许岭翎. 1型糖尿病诱发肌少症的研究进展[J]. 基础医学与临床, 2024, 44(8): 1189-1193.
[3]	张雅慧, 白琼. 低氧诱导因子-1α在糖尿病肾病中作用机制的研究进展[J]. 基础医学与临床, 2024, 44(1): 114-118.
[4]	党彩虹, 李维辛. 脂肪因子在老年人肌少症发病中作用的研究进展[J]. 基础医学与临床, 2023, 43(4): 695-699.
[5]	孙慧, 陈思宇. 微生物相关肿瘤的发病机制及其治疗的研究进展[J]. 基础医学与临床, 2023, 43(1): 178-182.
[6]	林柏柏, 钱风华, 钱义明, 赵雷, 孙旗, 褚梦瑶, 沈梦雯. 脓毒症并发毛细血管渗漏综合征的研究进展[J]. 基础医学与临床, 2022, 42(7): 1144-1147.
[7]	赵肖灵, 何润之, 孙玉姣, 张小冲, 杨林芳, 王瑞, 程芳. 活动期白癜风患者血清γ干扰素含量升高[J]. 基础医学与临床, 2022, 42(7): 1067-1070.
[8]	吴长宝, 郝延磊. STAT3与帕金森病发病机制的研究进展[J]. 基础医学与临床, 2022, 42(12): 1935-1938.
[9]	王行行, 王导新. NETs与急性呼吸窘迫综合征的研究进展[J]. 基础医学与临床, 2021, 41(7): 1047-1051.
[10]	邓玉洁, 李维辛. 运动改善肌少症的免疫机制研究进展[J]. 基础医学与临床, 2021, 41(6): 909-913.
[11]	兰菲, 刘太阳, 杨杰. 肠离子通道在肠易激综合征发病机制中的作用研究进展[J]. 基础医学与临床, 2020, 40(8): 1135-1139.
[12]	宋华琛唐晓楠张海婧王文杰吴练秋. 结肠炎相关结肠癌机制研究进展[J]. 基础医学与临床, 2018, 38(4): 568-572.
[13]	黄体龙杨跃煌张娴文. 间变性淋巴瘤激酶与神经母细胞瘤[J]. 基础医学与临床, 2018, 38(12): 1791-1794.
[14]	李甜甜张江宇李荔. PI3K/Akt在多囊卵巢综合征发病机制中作用的研究进展[J]. 基础医学与临床, 2016, 36(11): 1596-1602.
[15]	王威曹翠平陈颖张丹韩玲玲刘国良. 棕榈酸诱导胰岛素瘤细胞MIN6细胞凋亡[J]. 基础医学与临床, 2010, 30(4): 401-405.